Pacific Biosciences of California, Inc. Forecast, price target & analysts
Pacific Biosciences of California, Inc. Target price 2025 - Analyst rating & recommendation
Pacific Biosciences of California, Inc. Classifications & Recommendation:
Pacific Biosciences of California, Inc. Price Target
| Target Price | $2.54 |
| Price | $1.46 |
| Potential |
73.87%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Pacific Biosciences of California, Inc. 2026 .
The average Pacific Biosciences of California, Inc. target price is $2.54.
This is
73.87%
register free of charge
$6.00
310.96%
register free of charge
$1.00
31.51%
register free of charge
|
|
| A rating was issued by 16 analysts: 7 Analysts recommend Pacific Biosciences of California, Inc. to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Pacific Biosciences of California, Inc. stock has an average upside potential 2026 of
73.87%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 154.01 | 162.52 |
| 23.19% | 5.52% |
15 Analysts have issued a sales forecast Pacific Biosciences of California, Inc. 2025 . The average Pacific Biosciences of California, Inc. sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.12 | -0.74 |
| 7.44% | 33.93% | |
| P/E | negative | |
| EV/Sales | 4.20 |
15 Analysts have issued a Pacific Biosciences of California, Inc. forecast for earnings per share. The average Pacific Biosciences of California, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Pacific Biosciences of California, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Pacific Biosciences of California, Inc....
Current Pacific Biosciences of California, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler | Locked ➜ Locked | Locked | Feb 20 2025 |
| Goldman Sachs | Locked ➜ Locked | Locked | Feb 18 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Feb 18 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Feb 14 2025 |
| Goldman Sachs | Locked ➜ Locked | Locked | Jan 23 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Nov 11 2024 |
| UBS | Locked ➜ Locked | Locked | Nov 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler: Locked ➜ Locked
|
Feb 20 2025 |
|
Locked
Goldman Sachs: Locked ➜ Locked
|
Feb 18 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Feb 18 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Feb 14 2025 |
|
Locked
Goldman Sachs: Locked ➜ Locked
|
Jan 23 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Nov 11 2024 |
|
Locked
UBS: Locked ➜ Locked
|
Nov 11 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
